Developed & Manufactured by Biomedica

High quality ELISAs
Developed and manufactured by Biomedica

Featured Products & Promotions

Latest News
  • Developing PVOD-Specific Therapies
    Developing PVOD-Specific Therapies
    3 November, 2025
    Insights from animal models and MSC transplantation Pulmonary Veno-Occlusive Disease (PVOD), also known as "pulmonary arterial hypertension (PAH), is a rare form of pulmonary hypertension. It is caused by progressive blockage of small veins in the lungs leading to increased pressure followed by right-sided heart failure (1). As effective treatments are limited, lung transplantation remains [...]
  • Standardizing Sclerostin Measurement
    Standardizing Sclerostin Measurement
    29 October, 2025
    Sclerostin is a glycoprotein primarily produced by osteocytes, bone cells embedded within the bone matrix. It plays a crucial role in regulating bone metabolism by acting as Wnt signaling pathway antagonist, essential for promoting bone formation. By inhibiting this pathway, sclerostin effectively reduces osteoblast activity and bone formation, thereby maintaining a balance between bone growth [...]
  • DKK-1 linked to poor prognosis and metastasis in breast cancer
    DKK-1 linked to poor prognosis and metastasis in breast cancer
    20 October, 2025
    About Dickkopf-1 (DKK-1)  - a  key regulator of the Wnt signaling pathway DKK-1 is a protein that functions as a key regulator of the Wnt signaling pathway, which is essential for various cellular processes including growth, development, and tissue homeostasis. DKK-1 primarily acts as an antagonist of the Wnt pathway by binding to specific receptors, [...]
More News
Events
  • Biomedica at Osteologie in Salzburg
    19 June, 2023
    Biomedica features FGF23 ELISA - intact and C-terminal - assays Meet us at the OSTEOLOGIE Conference taking place from 22-24 June 2023 in Salzburg, Austria! We will exhibit at booth # 36 introducing our novel biomarker ELISA assays to investigate bone and cancer induced bone diseases (e.g. Periostin, Semaphorin 4D, LRG, and others). Our focus [...]
  • Biomedica @ Osteologie 2020 in Salzburg
    17 February, 2020
    Meet us at the Osteologie 2020, hosted by the Deutsche Gesellschaft für Endokrinologie and the Österreichische Gesellschaft für Knochen- und Mineralstoffwechsel, taking place from 12-14 March 2020 in Salzburg, Austria! We will exhibit together with our partners Fianostics & TAmiRNA at booth #1. Moreover,  we will present out new VEGF-A ELISA at our poster "Novel VEGF-A ELISA [...]
  • Meet Biomedica at ASN Kidney Week
    7 November, 2019
    Meet us during ASN Kidney Week taking place from November 5-10 2019 in Washington, DC at booth no. 2005 Hosted by the American Society of Nephrology it’s the world’s premier nephrology meeting with more than 13,000 kidney specialists from across the globe. It provides participants with exciting and challenging opportunities to exchange knowledge, learn about [...]
More Events